These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15448144)

  • 1. Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling.
    Fernández-Monreal M; López-Atalaya JP; Benchenane K; Cacquevel M; Dulin F; Le Caer JP; Rossier J; Jarrige AC; Mackenzie ET; Colloc'h N; Ali C; Vivien D
    J Biol Chem; 2004 Dec; 279(49):50850-6. PubMed ID: 15448144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.
    Lopez-Atalaya JP; Roussel BD; Levrat D; Parcq J; Nicole O; Hommet Y; Benchenane K; Castel H; Leprince J; To Van D; Bureau R; Rault S; Vaudry H; Petersen KU; Santos JS; Ali C; Vivien D
    J Cereb Blood Flow Metab; 2008 Jun; 28(6):1212-21. PubMed ID: 18334994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor.
    Ng KS; Leung HW; Wong PT; Low CM
    J Biol Chem; 2012 Jul; 287(30):25520-9. PubMed ID: 22610100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors.
    Yuan H; Vance KM; Junge CE; Geballe MT; Snyder JP; Hepler JR; Yepes M; Low CM; Traynelis SF
    J Biol Chem; 2009 May; 284(19):12862-73. PubMed ID: 19240037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.
    Benchenane K; Castel H; Boulouard M; Bluthé R; Fernandez-Monreal M; Roussel BD; Lopez-Atalaya JP; Butt-Gueulle S; Agin V; Maubert E; Dantzer R; Touzani O; Dauphin F; Vivien D; Ali C
    J Cell Sci; 2007 Feb; 120(Pt 4):578-85. PubMed ID: 17244650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors.
    Martin AM; Kuhlmann C; Trossbach S; Jaeger S; Waldron E; Roebroek A; Luhmann HJ; Laatsch A; Weggen S; Lessmann V; Pietrzik CU
    J Biol Chem; 2008 May; 283(18):12004-13. PubMed ID: 18321860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit.
    Ehlers MD; Zhang S; Bernhadt JP; Huganir RL
    Cell; 1996 Mar; 84(5):745-55. PubMed ID: 8625412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced ethanol inhibition of N-methyl-D-aspartate receptors by deletion of the NR1 C0 domain or overexpression of alpha-actinin-2 proteins.
    Anders DL; Blevins T; Smothers CT; Woodward JJ
    J Biol Chem; 2000 May; 275(20):15019-24. PubMed ID: 10809744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein.
    Masuko T; Kashiwagi K; Kuno T; Nguyen ND; Pahk AJ; Fukuchi J; Igarashi K; Williams K
    Mol Pharmacol; 1999 Jun; 55(6):957-69. PubMed ID: 10347236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.
    Gonias SL; Banki MA; Gilder AS; Azmoon P; Campana WM; Mantuano E
    J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29930084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke.
    Macrez R; Bezin L; Le Mauff B; Ali C; Vivien D
    Stroke; 2010 Dec; 41(12):2950-5. PubMed ID: 20966414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain.
    Tingley WG; Roche KW; Thompson AK; Huganir RL
    Nature; 1993 Jul; 364(6432):70-3. PubMed ID: 8316301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.
    Nicole O; Docagne F; Ali C; Margaill I; Carmeliet P; MacKenzie ET; Vivien D; Buisson A
    Nat Med; 2001 Jan; 7(1):59-64. PubMed ID: 11135617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.
    Lesept F; Chevilley A; Jezequel J; Ladépêche L; Macrez R; Aimable M; Lenoir S; Bertrand T; Rubrecht L; Galea P; Lebouvier L; Petersen KU; Hommet Y; Maubert E; Ali C; Groc L; Vivien D
    Cell Death Dis; 2016 Nov; 7(11):e2466. PubMed ID: 27831563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.
    Samson AL; Nevin ST; Croucher D; Niego B; Daniel PB; Weiss TW; Moreno E; Monard D; Lawrence DA; Medcalf RL
    J Neurochem; 2008 Nov; 107(4):1091-101. PubMed ID: 18796005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spatial model of the glycine site of the NR1 subunit of NMDA-receptor and ligand docking.
    Tikhonova IG; Baskin II; Palyulin VA; Zefirov NS
    Dokl Biochem Biophys; 2002; 382():67-70. PubMed ID: 11938676
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of amino acid substitutions in transmembrane domains of the NR1 subunit on the ethanol inhibition of recombinant N-methyl-D-aspartate receptors.
    Smothers CT; Woodward JJ
    Alcohol Clin Exp Res; 2006 Mar; 30(3):523-30. PubMed ID: 16499494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.